Free Trial
→ A New Way to Double Your Retirement Income? (From Investors Alley) (Ad)tc pixel

Bioventix (LON:BVXP) Shares Pass Below 200-Day Moving Average - Here's What Happened

Written by MarketBeat
September 8, 2025
Bioventix logo with Medical background

Key Points

  • Bioventix PLC shares have crossed below their 200-day moving average of GBX 2,671.70, indicating potential bearish sentiment as the stock traded as low as GBX 2,420.
  • The company has a low PE ratio of 1,639.21 and a market capitalization of £126.86 million, suggesting a highly valued stock relative to its earnings.
  • Bioventix specializes in creating and supplying sheep monoclonal antibodies for various diagnostic applications, including thyroid and cardiac health.
  • Five stocks we like better than Bioventix.

Shares of Bioventix PLC (LON:BVXP - Get Free Report) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 2,671.70 ($36.19) and traded as low as GBX 2,420 ($32.78). Bioventix shares last traded at GBX 2,428 ($32.89), with a volume of 5,452 shares traded.

Bioventix Stock Up 0.9%

The company has a fifty day moving average price of GBX 2,582.47 and a 200-day moving average price of GBX 2,664.31. The stock has a market capitalization of £128.01 million, a P/E ratio of 1,654.06 and a beta of 0.35.

About Bioventix

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.

See Also

Should You Invest $1,000 in Bioventix Right Now?

Before you consider Bioventix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioventix wasn't on the list.

While Bioventix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover
The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.